Laboratory investigations show that BPC-157 administration significantly enhances ERK1/2 phosphorylation in a dose-dependent manner, leading to increased endothelial cell proliferation, migration, and vascular tube formationthe central processes underlying functional angiogenesis in tissue regeneration contexts
Reduced appetite , which, while a therapeutic goal, may sometimes result in inadequate caloric intake if not monitored
Z.HalimH
If they do, this would also add evidence that this NNMT inhibitor improves muscle performance through increasing NAD+ levels
In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis